In two months, Russia is planning to send a new experimental vaccine against Ebola to Africa, according to the country’s health minister. The efficiency of the drug, which is to be tested on the ground, is about 70-90 percent.
“Today we are discussing that we will have enough of Triazoverin vaccine in two months so that we can send them to our personnel in Guinea and test its efficiency in clinical conditions,” Health Minister Veronika Skvortsova said.
The vaccine has so far proved efficient against various hemorrhagic fevers, including the Marburg virus which is very similar to Ebola.
“The efficiency ranges between 70 and 90 percent and this is a very good indicator,” Skvortsova said.
Russia’ Virology Institute is preparing a whole group of drugs.
“They are basically genetically engineered drugs which can work both for disease treatment and prevention,” Skvortsova said.
Russian virologists, who have set up a laboratory in Guinea, are preparing to test the vaccine on primates.